Merck (MRK) Long-Term Deferred Tax (2010 - 2023)

Merck (MRK) has 14 years of Long-Term Deferred Tax data on file, last reported at $10.2 billion in Q2 2023.

• Long-Term Deferred Tax for Q2 2023 came in at $10.2 billion, down 7.15% year-over-year; the trailing twelve-month figure through Jun 2023 was $10.2 billion (down 7.15% YoY), and the FY2022 annual result was $9.5 billion, down 17.73% from the prior year.
• Long-Term Deferred Tax retreated to $10.2 billion in Q2 2023 per MRK's latest filing, from $10.3 billion in the prior quarter.
• Over five years, Long-Term Deferred Tax peaked at $11.6 billion in Q4 2021 and troughed at $6.8 billion in Q4 2019.
• A 5-year average of $9.6 billion and a median of $9.7 billion in 2020 frame the typical range for Long-Term Deferred Tax.
• The sharpest annual moves came in 2020 and 2021: Long-Term Deferred Tax decreased 19.01% in 2020, then surged 48.7% in 2021.
• A 5-year view of Long-Term Deferred Tax shows it stood at $6.8 billion in 2019, then soared by 45.93% to $9.9 billion in 2020, then climbed by 17.21% to $11.6 billion in 2021, then decreased by 17.73% to $9.5 billion in 2022, then advanced by 6.92% to $10.2 billion in 2023.
• Business Quant data shows MRK's Long-Term Deferred Tax at $10.2 billion in Q2 2023, $10.3 billion in Q1 2023, and $9.5 billion in Q4 2022.